Aim of TB Eradication in India by 2025 is Undoubtedly Unrealistic.

Autor:	Chennamchetty, Vijay Kumar
Předmět:	PREVENTION of infectious disease transmission TUBERCULOSIS epidemiology PREVENTION of drug side effects ANTIBIOTICS TUBERCULOSIS diagnosis TUBERCULOSIS prevention DRUG therapy for tuberculosis COVID-19 EXTRAPULMONARY tuberculosis POST-acute COVID-19 syndrome MEDICAL technology INVESTIGATIONAL drugs GOVERNMENT programs PREVENTIVE health services INFECTION control MEDICAL protocols ANTITUBERCULAR agents DRUGS MIXED infections TUBERCULOSIS IMMUNITY PATIENT compliance PROPRIETARY hospitals GOAL (Psychology) HEALTH promotion EARLY diagnosis DIFFUSION of innovations NUCLEIC acid amplification techniques MEDICAL research DISEASE risk factors
Zdroj:	Indian Practitioner; Apr2023, Vol. 76 Issue 4, p34-38, 5p
Abstrakt:	The article focuses on the reasons for the prevalence of Multidrug Resistant Tuberculosis (MDR TB) and the impact of COVID-19 on Tuberculosis. Topics include the spread of MDR TB due to irregular treatment and poor adherence to medications, the importance of early diagnosis using molecular tests, and the challenges faced in managing TB during the COVID-19 pandemic.
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu